Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline

NCT00099567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2632

Last updated 2005-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kristine Yaffe, MD · University of California, San Francisco

Eligibility

Min Age
70 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-01-31
Completion
2002-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00099567 on ClinicalTrials.gov